Wacholtz MC - Search Results

1

Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4.

Bachelez H, Flageul B, Dubertret L, Fraitag S, Grossman R, Brousse N, Poisson D, Knowles RW, Wacholtz MC, Haverty TP, Chatenoud L, Bach JF. Bachelez H, et al. Among authors: wacholtz mc. J Autoimmun. 1998 Feb;11(1):53-62. doi: 10.1006/jaut.1997.0175. J Autoimmun. 1998. PMID: 9480723

2

Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4.

Schulze-Koops H, Davis LS, Haverty TP, Wacholtz MC, Lipsky PE. Schulze-Koops H, et al. Among authors: wacholtz mc. J Rheumatol. 1998 Nov;25(11):2065-76. J Rheumatol. 1998. PMID: 9818646 Clinical Trial.

3

Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis.

Moreland LW, Haverty TP, Wacholtz MC, Knowles RW, Bucy RP, Heck LW Jr, Koopman WJ. Moreland LW, et al. Among authors: wacholtz mc. J Rheumatol. 1998 Feb;25(2):221-8. J Rheumatol. 1998. PMID: 9489810 Clinical Trial.

4

Treatment of lupus nephritis with CD5 PLUS, an immunoconjugate of an anti-CD5 monoclonal antibody and ricin A chain.

Wacholtz MC, Lipsky PE. Wacholtz MC, et al. Arthritis Rheum. 1992 Jul;35(7):837-9. doi: 10.1002/art.1780350721. Arthritis Rheum. 1992. PMID: 1377918 No abstract available.

5

A Na(+)-dependent Ca2+ exchanger generates the sustained increase in intracellular Ca2+ required for T cell activation.

Wacholtz MC, Cragoe EJ Jr, Lipsky PE. Wacholtz MC, et al. J Immunol. 1992 Sep 15;149(6):1912-20. J Immunol. 1992. PMID: 1387665

6

Comparison of the capacity of murine and human class I MHC molecules to stimulate T cell activation.

Gur H, Wacholtz MC, Lie WR, Lipsky PE, Geppert TD. Gur H, et al. Among authors: wacholtz mc. Cell Immunol. 1992 Oct 15;144(2):392-406. doi: 10.1016/0008-8749(92)90254-m. Cell Immunol. 1992. PMID: 1394450

7

Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.

Vasquez S, Kavanaugh AF, Schneider NR, Wacholtz MC, Lipsky PE. Vasquez S, et al. Among authors: wacholtz mc. J Rheumatol. 1992 Oct;19(10):1625-7. J Rheumatol. 1992. PMID: 1464880

8

Modulatory effect of aggregating the CD3 molecular complex on T cell activation.

Gur H, Wacholtz MC, Davis LS, Geppert TD, Lipsky PE. Gur H, et al. Among authors: wacholtz mc. Cell Immunol. 1992 Mar;140(1):81-96. doi: 10.1016/0008-8749(92)90178-r. Cell Immunol. 1992. PMID: 1531456

9

Delineation of the mechanism of inhibition of human T cell activation by PGE2.

Minakuchi R, Wacholtz MC, Davis LS, Lipsky PE. Minakuchi R, et al. Among authors: wacholtz mc. J Immunol. 1990 Oct 15;145(8):2616-25. J Immunol. 1990. PMID: 1976699

10

Accessory cell signals involved in T-cell activation.

Geppert TD, Davis LS, Gur H, Wacholtz MC, Lipsky PE. Geppert TD, et al. Among authors: wacholtz mc. Immunol Rev. 1990 Oct;117:5-66. doi: 10.1111/j.1600-065x.1990.tb00566.x. Immunol Rev. 1990. PMID: 2147918 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters